ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,548,081 | -11.1% | 75,553 | -13.7% | 0.00% | 0.0% |
| Q2 2023 | $1,740,533 | +43.7% | 87,596 | +23.8% | 0.00% | +100.0% |
| Q1 2023 | $1,211,622 | -5.4% | 70,731 | +8.0% | 0.00% | 0.0% |
| Q4 2022 | $1,281,346 | +157.8% | 65,475 | +110.2% | 0.00% | 0.0% |
| Q3 2022 | $497,000 | +15.9% | 31,154 | -0.2% | 0.00% | – |
| Q2 2022 | $429,000 | -10.8% | 31,221 | +2.9% | 0.00% | – |
| Q1 2022 | $481,000 | -22.2% | 30,345 | +7.2% | 0.00% | – |
| Q4 2021 | $618,000 | -22.5% | 28,302 | +6.2% | 0.00% | – |
| Q3 2021 | $797,000 | -26.7% | 26,659 | +8.6% | 0.00% | -100.0% |
| Q2 2021 | $1,087,000 | -0.1% | 24,553 | +0.1% | 0.00% | 0.0% |
| Q1 2021 | $1,088,000 | -19.6% | 24,523 | -0.6% | 0.00% | 0.0% |
| Q4 2020 | $1,354,000 | -13.8% | 24,668 | -64.1% | 0.00% | 0.0% |
| Q3 2020 | $1,570,000 | +94.5% | 68,646 | +78.0% | 0.00% | 0.0% |
| Q2 2020 | $807,000 | -28.1% | 38,557 | -21.8% | 0.00% | 0.0% |
| Q4 2019 | $1,122,000 | +35.0% | 49,289 | -31.0% | 0.00% | 0.0% |
| Q3 2019 | $831,000 | +7.1% | 71,395 | +37.9% | 0.00% | 0.0% |
| Q2 2019 | $776,000 | +163.9% | 51,758 | +209.4% | 0.00% | – |
| Q1 2019 | $294,000 | -28.5% | 16,731 | -39.7% | 0.00% | – |
| Q4 2018 | $411,000 | +68.4% | 27,765 | +180.9% | 0.00% | – |
| Q3 2018 | $244,000 | -28.9% | 9,885 | -43.5% | 0.00% | – |
| Q2 2018 | $343,000 | – | 17,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |